U.S. patients seek stem cell treatments in China

06/6/2010 | Washington Post, The

Some U.S. patients with cerebral palsy and other diseases are undergoing experimental stem cell treatments in China, a trend that Western scientists say could jeopardize the health of patients. Moreover, the stem cells used in most clinics in the country are derived from miscarried fetuses, a practice that raises ethical and religious concerns.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ